Comparative study of the inhibitory effects of adrenomedullin on angiotensin II contraction in rat conductance and resistance arteries

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 5, Issue 2, 2004, Pages 79-83

  Haulica, Ion ^a   Bild, Walther ^b   Mihaila, Christian ^b   Serban, Dragomir N ^b   Serban, Lacramioara ^b   Boisteanu, Daniela ^b   Ionita, Teodor ^a   Radasanu, Oana ^a  

^a ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Andrenomedullin; Angiotensin II; Guanylate cyclase; L NAME; Methylene blue

Indexed keywords

ADRENOMEDULLIN; ANGIOTENSIN; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL TONE; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; HORMONE INHIBITION; MALE; MESENTERIC ARTERY; NONHUMAN; PROTEIN INTERACTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION;

EID: 3543002868     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2004.014     Document Type: Article

References (31)

1. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheocromocytoma. Biochem Biophys Res Commun 1993;192:553-60.
2. Hinson JP, Kapas I, Smith DM. Adrenomedullin, a multi-functional regulatory peptide. Endocrine Rev 2000; 21:138-67.
3. Ishimitsu T, Kojima M, Kangawa K, Hino J, Kitamura K. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994;203:631-9.
4. Samson WK. Proadrenomedullin-derived peptides. Front Neuroendocrinol 1998;19:100-27.
5. Poyner D, Sexton PM, Marshall I, Smith DM, Foord SM. Mammalian calcitonin gene-related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev 2000;54:233-46.
6. Wangensteen R, Quesada A, Sainz J, Duarte J, Vargas F, Osuna A. Role of endothelium-derived relaxing factors in adrenomedullin induced vasodilation in the rat kidney. Eur J Pharmacol 2002;444:97-102.
7. Eto T, Kitamura K, Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999;26:371-80.
8. Shirai M, Shimouchi A, Ikeda S, Kanagawa K, Matsuo H. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. Brit J Pharmacol 1997;121:679-86.
9. Barber DA, Park YS, Burnett JC, Miller VM.Adrenomedullin-mediated relaxations in vein are endothelium-dependent and distinct from arteries. J Cardiovasc Pharmacol 1997;30:695-701.
10. Chu DQ, Smith DM, Brain SD. Studies of the micro vascular effects of adrenomedullin and related peptides. Peptides 2001;22:1881-6.
11. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, Eto T. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995;202: 37-40.
12. Ueta Y, Serino R, Shibuya I, Kitamura K, Russell JA. A physiological role for adrenomedullin in rats: a potent hypotensive peptide in the hypothalamo-neurohypophysial system. Exp Physiol 2000;85S:163-9.
13. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Marumo F. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340:226-30.
14. Coppock HA, Owji AA, Bloom SR, Smith DM. A rat skeletal muscle cell line expresses specific adrenomedullin binding sites but activates adenylate cyclase via CGRP receptors. Biochem J 1996;318:241-5.
15. Lang MG, Paterno R, Faraci FM, Heistad DD. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 1997;28:181-5.
16. Hayakawa H, Hirata Y, Kakoki M et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilatation in the rat. Hypertension 1999;33:689-93.
17. Fujioka H, Okamura I, Toda N. Inhibition by adrenomedullin of amine release from adrenergic nerves in dog mesenteric arteries. Eur J Pharmacol 1999;385:155-61.
18. Berthiaume N, Claing A, Lippton H, Cadieux A, D'Orleans-Just P. Rat adrenomedullin induces a selective arterial vasodilatation via CGRP-1 receptors in the double-perfused mesenteric bed of the rat. Canad J Physiol Pharmacol 1995;73: 1080-3.
19. Samson WK, Resch ZT, Murphy TC, Vargas T, Schell DA. Adrenomedullin: is there physiological relevance in the pathology and pharmacology? New Physiol Sci 1999;14:255-9.
20. Ando K, Ito Y, Kumada M, Fujita T. Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res Clin Exp 1998;21:187-91.
21. Krzeminski K, Mikulski T, Kruk B, Nazar K. Plasma adrenomedullin response to maximal exercise in healthy subjects. J Physiol Pharmacol 2003;54:225-32.
22. Jensen BL, Kramer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997;29:1148-58.
23. Andreis PG, Mazzochi G, Rebufatt P, Nussdorfer GG. Effects of adrenomedullin and PAMP on rat zona glomerulosa cells. Life Sci 1997;60:1693-7.
24. Petrie MC, Hillier C, Morton JJ, Mc Murray J. Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens 2000;18:61-4.
25. Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regulatory Peptides 2003;112:61-9.
26. Charles CJ, Lainchbury JG, Nicholls MG, Rademacher MT, Troughton RW. Adrenomedullin and the renin-angiotensin-aldosterone system. Regulatory Peptides 2003;112:41-9.
27. Moncada S. The arginine-nitric oxide pathway. Acta Physiol Scand 1992;145:210-27.
28. Abdullah K, Cawley T, Connolly C, Ruiz E, Docherty JR. Comparison of the effects of nitric oxide synthase inhibition and guanylate cyclase inhibition on vascular contraction in vitro and in vivo in the rat. Naunyn Schmiedebergs Arch Pharmacol 1997;356:481-7.
29. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature 1976;260:617-19.
30. Haulica I, Todiras M, Brailoiu E, Baltatu O. Modulatory role of nitric oxide on angiotensins vasoconstriction. Rom J Physiol 1996; 33:83-90.
31. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.